• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA puts hold on Gilead's blood cancer therapy trials

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 07, 2024 at 09:22: PM
via Gilead Sciences (GILD.O), opens new tab said on Wednesday the U.S. Food and Drug Administration had put a hold on trials testing the company's blood cancer drug following increased risk of patient death in some studies.

article source
 




Top Bottom
Back
Quote